Answers are grounded in this paper and cite their sources.
Background & Objective: Obesity is a major public health problem whose prevalence has constantly increased worldwide.Obesity is a risk factor for several diseases such as type 2 diabetes, fatty liver disease, hyperlipidemia, cardiovascular diseases, and cancer, all of which reduce the quality of life and life expectancy.This study investigated anti-adipogenic effects of Eryngium billardierei (Ery) extract. Materials & Methods:The nontoxic concentration of Ery extract was estimated via the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazoliu bromide (MTT) assay.The differentiation of mouse-derived 3T3-L1 preadipocytes into mature adipocytes was induced in the presence or absence of Ery extract.Then, the accumulation of lipid droplets was identified by Oil Red O staining.Triacylglycerol level and glycerol-3phosphate dehydrogenase (GPDH) activity were also measured. Results:The MTT assay showed that 3 mg/mL of the Ery extract can be a nontoxic dose for other analyses.Oil Red O staining demonstrated a reduction of lipid droplets in the extract-treated adipocyte 3T3-L1 compared to the non-treated group.A significant decrease of triacylglycerol level in the treated 3T3-L1 adipocyte (0.32±0.03 mgTG/mg protein) compared with the nontreated group (0.78±0.05 mgTG/mg protein) (P<0.01), and a significant decrease of glycerol-3-phosphate dehydrogenase (GPDH) activity in the 3T3-L1adipocyte treated (15.3±2.1 U/ml) compared to the non-treated group (30.2±3.9U/ml) (P<0.05)confirmed the inhibitory action of Ery extract on adipocyte differentiation. Conclusion:Ery extract, as a safe herbal extract, has anti-adipogenic activity and merits more investigation as a candidate for developing an anti-obesity drug or supplement.
No takes yet. Share an insight, caveat, or question.
Heidari et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: